Skip Nav Destination
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome–positive leukemias
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
Issue Archive
Table of Contents
INSIDE BLOOD
ASH 50TH ANNIVERSARY REVIEW
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
Clinical Trials & Observations
Gilles Salles,Nicolas Mounier,Sophie de Guibert,Franck Morschhauser,Chantal Doyen,Jean-François Rossi,Corinne Haioun,Pauline Brice,Béatrice Mahé,Reda Bouabdallah,Bruno Audhuy,Christophe Ferme,Caroline Dartigeas,Pierre Feugier,Catherine Sebban,Luc Xerri,Charles Foussard
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
Clinical Trials & Observations
Rob Pieters,Inge Appel,Hans-Juergen Kuehnel,Iris Tetzlaff-Fohr,Uwe Pichlmeier,Inekee van der Vaart,Eline Visser,Rolinda Stigter
GENE THERAPY
HEMATOPOIESIS AND STEM CELLS
Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5
Ryan D. Schulteis,Haiyan Chu,Xuezhi Dai,Yuhong Chen,Brandon Edwards,Dipica Haribhai,Calvin B. Williams,Subramaniam Malarkannan,Martin J. Hessner,Sanja Glisic-Milosavljevic,Srikanta Jana,Edward J. Kerschen,Soumitra Ghosh,Demin Wang,Anne E. Kwitek,Ake Lernmark,Jack Gorski,Hartmut Weiler
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
David C. Johnson,Sophie Corthals,Christine Ramos,Antje Hoering,Kim Cocks,Nicholas J. Dickens,Jeff Haessler,Harmut Goldschmidt,J. Anthony Child,Sue E. Bell,Graham Jackson,Dalsu Baris,S. Vincent Rajkumar,Faith E. Davies,Brian G. M. Durie,John Crowley,Pieter Sonneveld,Brian Van Ness,Gareth J. Morgan
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Brief Report
Veronique Frémeaux-Bacchi,Elizabeth C. Miller,M. Kathryn Liszewski,Lisa Strain,Jacques Blouin,Alison L. Brown,Nadeem Moghal,Bernard S. Kaplan,Robert A. Weiss,Karl Lhotta,Gaurav Kapur,Tej Mattoo,Hubert Nivet,William Wong,Sophie Gie,Bruno Hurault de Ligny,Michel Fischbach,Ritu Gupta,Richard Hauhart,Vincent Meunier,Chantal Loirat,Marie-Agnès Dragon-Durey,Wolf H. Fridman,Bert J. C. Janssen,Timothy H. J. Goodship,John P. Atkinson
IMMUNOBIOLOGY
Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions
Liat Flaishon,Gili Hart,Einat Zelman,Christine Moussion,Valentin Grabovsky,Guy Lapidot Tal,Sara Feigelson,Raanan Margalit,Alon Harmelin,Tamar Avin-Wittenberg,David Shoseyov,Ronen Alon,Jean-Philippe Girard,Idit Shachar
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
Lucy A. Truman,Catriona A. Ford,Marta Pasikowska,John D. Pound,Sarah J. Wilkinson,Ingrid E. Dumitriu,Lynsey Melville,Lauren A. Melrose,Carol Anne Ogden,Robert Nibbs,Gerard Graham,Christophe Combadiere,Christopher D. Gregory
A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion
Gaël Ménasché,Mickaël M. Ménager,Juliette M. Lefebvre,Einat Deutsch,Rafika Athman,Nathalie Lambert,Nizar Mahlaoui,Magali Court,Jérôme Garin,Alain Fischer,Geneviève de Saint Basile
NEOPLASIA
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor–CD3 expression in enteropathy-associated T-cell lymphoma
Jennifer M. L. Tjon,Wieke H. M. Verbeek,Yvonne M. C. Kooy-Winkelaar,Binh H. Nguyen,Arno R. van der Slik,Allan Thompson,Mirjam H. M. Heemskerk,Marco W. J. Schreurs,Liesbeth H. A. Dekking,Chris J. Mulder,Jeroen van Bergen,Frits Koning
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
Sophia Adamia,Amanda A. Reichert,Hemalatha Kuppusamy,Jitra Kriangkum,Anirban Ghosh,Jennifer J. Hodges,Patrick M. Pilarski,Steven P. Treon,Michael J. Mant,Tony Reiman,Andrew R. Belch,Linda M. Pilarski
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
Lindsay M. Morton,Sophia S. Wang,Wendy Cozen,Martha S. Linet,Nilanjan Chatterjee,Scott Davis,Richard K. Severson,Joanne S. Colt,Mohammad A. Vasef,Nathaniel Rothman,Aaron Blair,Leslie Bernstein,Amanda J. Cross,Anneclaire J. De Roos,Eric A. Engels,David W. Hein,Deirdre A. Hill,Linda E. Kelemen,Unhee Lim,Charles F. Lynch,Maryjean Schenk,Sholom Wacholder,Mary H. Ward,Shelia Hoar Zahm,Stephen J. Chanock,James R. Cerhan,Patricia Hartge
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells
Ellen Weisberg,Johannes Roesel,Guido Bold,Pascal Furet,Jingrui Jiang,Jan Cools,Renee D. Wright,Erik Nelson,Rosemary Barrett,Arghya Ray,Daisy Moreno,Elizabeth Hall-Meyers,Richard Stone,Ilene Galinsky,Edward Fox,Gary Gilliland,John F. Daley,Suzan Lazo-Kallanian,Andrew L. Kung,James D. Griffin
Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells
Rosa Lapalombella,Bo Yu,Georgia Triantafillou,Qing Liu,Jonathan P. Butchar,Gerard Lozanski,Asha Ramanunni,Lisa L. Smith,William Blum,Leslie Andritsos,Da-Sheng Wang,Amy Lehman,Ching-Shih Chen,Amy J. Johnson,Guido Marcucci,Robert J. Lee,L. James Lee,Susheela Tridandapani,Natarajan Muthusamy,John C. Byrd
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome–positive leukemias
Brief Report
Dan Jones,Rajyalakshmi Luthra,Jorge Cortes,Deborah Thomas,Susan O'Brien,Carlos Bueso-Ramos,Seema Hai,Farhad Ravandi,Marcos de Lima,Hagop Kantarjian,Jeffrey L. Jorgensen
PHAGOCYTES
CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks
Karen E. Anderson,Keith B. Boyle,Keith Davidson,Tamara A. M. Chessa,Suhasini Kulkarni,Gavin E. Jarvis,Anca Sindrilaru,Karin Scharffetter-Kochanek,Oliver Rausch,Len R. Stephens,Phillip T. Hawkins
RED CELLS
TRANSPLANTATION
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
Brief Report
Sydney X. Lu,Onder Alpdogan,Janine Lin,Robert Balderas,Roberto Campos-Gonzalez,Xiao Wang,Guo-Jian Gao,David Suh,Christopher King,Melanie Chow,Odette M. Smith,Vanessa M. Hubbard,Johanne L. Bautista,Javier Cabrera-Perez,Johannes L. Zakrzewski,Adam A. Kochman,Andrew Chow,Gregoire Altan-Bonnet,Marcel R. M. van den Brink
ERRATUM
-
Cover Image
Cover Image
Presence of α4 integrin–rich trailing edge tethers in T cells from mice with disruption of α4 integrin salt bridges, resulting in impaired migration on VCAM-1. α4 integrin staining in red, actin staining in green. For details see the article by Imai et al on page 5007.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals